Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Y Ma

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
Cancer Letters|September 18, 2013
Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer modelsBrigette B Y Ma, Vivian W Y Lui, Connie W C Hui, et al.
European Radiology|March 24, 2019
Distinguishing early-stage nasopharyngeal carcinoma from benign hyperplasia using intravoxel incoherent motion diffusion-weighted MRIQi-Yong Ai, Ann D King, Janet S M Chan, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|July 6, 2010
Evaluation of risk assessment tools and infectious aetiology in cancer patients with fever and neutropaenia in Hong KongE P Hui, L K S Leung, F Mo, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|December 5, 2018
Amide proton transfer MRI detects early changes in nasopharyngeal carcinoma: providing a potential imaging marker for treatment responseSahrish Qamar, Ann D King, Qi-Yong Ai, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 6, 2012
Pseudoprogression of malignant glioma in Chinese patients receiving concomitant chemoradiotherapyDanny T M Chan, Rebecca Y T Ng, Deyond Y W Siu, et al.
Investigational New Drugs|June 19, 2015
Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079)B B Y Ma, B C Goh, W T Lim, et al.
British Journal of Cancer|March 3, 2011
Clinical significance of CDX2-positive circulating tumour cells in colorectal cancer patientsS C C Wong, S S M Ng, M T Cheung, et al.
Theranostics|October 3, 2022
MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic targetYifei Wang, Huarong Chen, Weixin Liu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 8, 2010
Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural networkEdwin Pun Hui, Linda K S Leung, Terence C W Poon, et al.
Cancer Cell|March 7, 2025
Fragmentomics profiling and quantification of plasma Epstein-Barr virus DNA enhance prediction of future nasopharyngeal carcinomaW K Jacky Lam, Guannan Kang, Charles M L Chan, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Cancer Letters|September 18, 2013
Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer modelsBrigette B Y Ma, Vivian W Y Lui, Connie W C Hui, et al.
European Radiology|March 24, 2019
Distinguishing early-stage nasopharyngeal carcinoma from benign hyperplasia using intravoxel incoherent motion diffusion-weighted MRIQi-Yong Ai, Ann D King, Janet S M Chan, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|July 6, 2010
Evaluation of risk assessment tools and infectious aetiology in cancer patients with fever and neutropaenia in Hong KongE P Hui, L K S Leung, F Mo, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|December 5, 2018
Amide proton transfer MRI detects early changes in nasopharyngeal carcinoma: providing a potential imaging marker for treatment responseSahrish Qamar, Ann D King, Qi-Yong Ai, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 6, 2012
Pseudoprogression of malignant glioma in Chinese patients receiving concomitant chemoradiotherapyDanny T M Chan, Rebecca Y T Ng, Deyond Y W Siu, et al.
Investigational New Drugs|June 19, 2015
Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079)B B Y Ma, B C Goh, W T Lim, et al.
British Journal of Cancer|March 3, 2011
Clinical significance of CDX2-positive circulating tumour cells in colorectal cancer patientsS C C Wong, S S M Ng, M T Cheung, et al.
Theranostics|October 3, 2022
MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic targetYifei Wang, Huarong Chen, Weixin Liu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 8, 2010
Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural networkEdwin Pun Hui, Linda K S Leung, Terence C W Poon, et al.
Cancer Cell|March 7, 2025
Fragmentomics profiling and quantification of plasma Epstein-Barr virus DNA enhance prediction of future nasopharyngeal carcinomaW K Jacky Lam, Guannan Kang, Charles M L Chan, et al.
Pageof 15